Navigation Links
Akaza Research to Present and Exhibit at Upcoming DIA Annual Meeting
Date:6/5/2009

Akaza Research CEO will be presenting at the upcoming DIA annual meeting. In addition, Akaza Research will be be exhibiting OpenClinica, the popular open source clinical trials software.

Cambridge, MA (PRWEB) June 5, 2009 -- Akaza Research is pleased to announce that Chief Executive Officer Cal Collins will deliver a presentation at the Drug Information Association's (DIA's) 45th Annual Meeting, June 21-25, in San Diego, CA. The session, titled "Utilizing and Integrating Open Source Software in Clinical Research Environments," will explore how open source, standards-based software can improve flexibility, interoperability, and cost in clinical trials.

At the event Akaza Research will also be exhibiting OpenClinica, its flagship open source clinical trials software product for electronic data capture (EDC) and clinical data management in. Personnel from Akaza Research will be on-hand to demonstrate OpenClinica and answer questions.

About OpenClinica®

OpenClinica is open source, web-based clinical trials software for electronic data capture (EDC) and clinical data management (CDM). OpenClinica facilitates data collection via electronic case report forms (eCRFs), and provides tools for data management and productive monitoring of clinical trials. OpenClinica supports leading CDISC standards and is designed to be compliant with industry and government regulations and guidelines such as 21 CFR Part 11, GCP, and HIPAA. OpenClinica is professionally supported by Akaza Research and has a worldwide open source community of over 6,000 users and developers. All versions of OpenClinica are freely available for download and use from http://www.openclinica.org.

About Akaza Research®

Akaza Research provides professional open source software for clinical trials. The company's flagship product, OpenClinica, provides electronic data capture (EDC) and clinical data management (CDM) capabilities for clinical research. By bringing open source software into the mainstream of clinical research, Akaza is able to provide a cost effective technology solution that is more flexible and transparent than proprietary, closed systems. Akaza Research provides a full spectrum of OpenClinica-related products and services to a worldwide customer base through its OpenClinica EnterpriseTM solution. For more information about Akaza Research, see http://www.akazaresearch.com.

# # #

Read the full story at http://www.prweb.com/releases/openclinica/clinical-trials-software/prweb2496654.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Akaza Research Releases New Version of OpenClinica Electronic Data Capture (EDC) Software; Targets Industry Clinical Trials
2. Akaza Research to Present OpenClinica at ACRP Global Conference & Exhibition
3. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
6. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
7. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
8. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
9. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience
10. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
11. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , ... October 12, 2017 ... ... has launched Rosalind™, the first-ever genomics analysis platform specifically designed for life ... Named in honor of pioneering researcher Rosalind Franklin, who made a major ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ComplianceOnline’s Medical ... place on 7th and 8th June 2018 in San Francisco, CA. The Summit brings ... well as several distinguished CEOs, board directors and government officials from around the world ...
(Date:10/11/2017)... Tbilisi, Georgia (PRWEB) , ... October 11, 2017 , ... ... disaster, taking the lives of over 5.5 million people each year. Especially those living ... the greenovative startup Treepex - based in one of the most pollution-affected countries globally ...
(Date:10/10/2017)... (PRWEB) , ... October 10, ... ... development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed ... targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with ...
Breaking Biology Technology:
(Date:4/19/2017)... ALBANY, New York , April 19, 2017 /PRNewswire/ ... highly competitive, as its vendor landscape is marked by ... in the market is however held by five major ... and Safran. Together these companies accounted for nearly 61% ... majority of the leading companies in the global military ...
(Date:4/13/2017)... MONICA, Calif. , April 13, 2017 ... New York will feature emerging and evolving ... Summits. Both Innovation Summits will run alongside the expo ... of speaker sessions, panels and demonstrations focused on trending ... coast,s largest advanced design and manufacturing event will take ...
(Date:4/11/2017)... , Apr. 11, 2017 Research and ... Market 2017-2021" report to their offering. ... The global eye tracking market to grow at a ... report, Global Eye Tracking Market 2017-2021, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
Breaking Biology News(10 mins):